Pharmacologic Relapse Prevention for Alcoholic Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

April 30, 2002

Study Completion Date

August 31, 2007

Conditions
AlcoholismSmoking
Interventions
DRUG

bupropion (Wellbutrin)

"1 pill in the am of 150 mg of Bupropion~1 pill (150 mg) in the AM and one in the PM for a total of 300 mg per day for subsequent 44 weeks."

DRUG

Placebo

placebo pill to match (look alike) the 150 mg pill of the bupropion given in the am for 3 days and then two pills (one in the morning and one at night) for the subsequent 44 mg.

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Mayo Clinic

OTHER